These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2519631)
1. Comparative study of the biological characteristics of mucoid and non-mucoid Pseudomonas aeruginosa strains isolated from chronic respiratory infections. Meitert E; Sima F; Savulian C; Chersulick E; Sălăgeanu A Arch Roum Pathol Exp Microbiol; 1989; 48(3):193-207. PubMed ID: 2519631 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and antimicrobial susceptibility of Pseudomonas aeruginosa mucoid and non-mucoid type. Srifuengfung S; Tiensasitorn C; Yungyuen T; Dhiraputra C Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):893-6. PubMed ID: 15916087 [TBL] [Abstract][Full Text] [Related]
3. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175 [TBL] [Abstract][Full Text] [Related]
4. [Comparative study of the antibiograms as well as serotype and virulence of Ps. aeruginosa cultures]. Sobolev VR; Vlasova IV; Solov'eva VE; Bogdanova LF; Smirnova NE Antibiotiki; 1975 Jun; 20(6):529-32. PubMed ID: 817653 [TBL] [Abstract][Full Text] [Related]
5. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia]. Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981 [TBL] [Abstract][Full Text] [Related]
6. Significance of human beta-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections. Yanagi S; Ashitani J; Imai K; Kyoraku Y; Sano A; Matsumoto N; Nakazato M Clin Microbiol Infect; 2007 Jan; 13(1):63-9. PubMed ID: 17184289 [TBL] [Abstract][Full Text] [Related]
7. [Serum sensitivity of Pseudomonas aeruginosa isolated from sputum as a virulence factor in the lower respiratory tract]. Sonoda F; Oishi K; Tanaka H; Hideaki M; Kobayashi S; Nagatake T; Matsumoto K Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jun; 29(6):703-9. PubMed ID: 1910122 [TBL] [Abstract][Full Text] [Related]
8. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
9. Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections. Maciá MD; Mena A; Borrell N; Pérez JL; Oliver A Antimicrob Agents Chemother; 2007 Dec; 51(12):4531-2. PubMed ID: 17893154 [No Abstract] [Full Text] [Related]
10. [Sensitivity of clinical Ps. aeruginosa strains to antibiotics]. Suiumova AS; Iskhakova KhI; Bazhenov LG Antibiotiki; 1982 Jun; 27(6):413-6. PubMed ID: 6810753 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre. Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511 [TBL] [Abstract][Full Text] [Related]
12. Are clinical isolates of Pseudomonas aeruginosa more virulent than hospital environmental isolates in amebal co-culture test? Fenner L; Richet H; Raoult D; Papazian L; Martin C; La Scola B Crit Care Med; 2006 Mar; 34(3):823-8. PubMed ID: 16505663 [TBL] [Abstract][Full Text] [Related]
13. Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains. Chifiriuc MC; Diţu LM; Banu O; Bleotu C; Drăcea O; Bucur M; Larion C; Israil AM; Lazăr V Roum Arch Microbiol Immunol; 2009; 68(1):27-33. PubMed ID: 19507624 [TBL] [Abstract][Full Text] [Related]
14. [Comparative study of the resistance of hospital and nonhospital strains of Pseudomonas aeruginosa to antibacterial preparations]. Krasil'nikov AP; Adarchenko AA; Krylov IA Antibiotiki; 1982 Jan; 27(1):25-9. PubMed ID: 6800301 [TBL] [Abstract][Full Text] [Related]
15. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. Hansen CR; Pressler T; Høiby N J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078 [TBL] [Abstract][Full Text] [Related]
18. Activity of some antibiotics against Pseudomonas aeruginosa strains isolated from cancerous patients. Del Piano M; Nicosia R; La Palombara P; Chiarini F Boll Ist Sieroter Milan; 1984 Jul; 63(3):181-7. PubMed ID: 6095882 [TBL] [Abstract][Full Text] [Related]
19. Comparison of some adhesive properties of Pseudomonas aeruginosa strains isolated from respiratory and urinary tract infections. Izdebska-Szymona K; Laziuk D Acta Microbiol Pol; 1988; 37(3-4):281-93. PubMed ID: 2470239 [TBL] [Abstract][Full Text] [Related]
20. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study. Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]